Research and Markets: Asia Pacific Cardiac Pacemaker Market Outlook to 2019 - Rise in Cardiac Disorders and Growing Awareness among People to Drive the Demand

Research and Markets (http://www.researchandmarkets.com/research/fc6mpn/asia_pacific) has announced the addition of the "Asia Pacific Cardiac Pacemaker Market Outlook to 2019 - Rise in Cardiac Disorders and Growing Awareness among People to Drive the Demand" report to their offering.

The market is dominated by few global players including Medtronic, Biotronik, Boston scientific and others.

The report titled 'Asia Pacific Cardiac Pacemaker Market Outlook to 2019 - Rise in Cardiac Disorders and Growing Awareness among People to Drive the Demand' provides a comprehensive analysis of cardiac pacemaker market in Asia. The report covers various aspects such as market size of cardiac pacemaker market, segmentation on the basis of therapeutic specification, implantability, number of chambers, and volume of exports and imports for cardiac pacemakers. The report is useful for pharmaceuticals companies, retail chains, consultants, healthcare professionals and new players venturing in the market.

The main competitors in India oncology space include Boston scientific, Medtronic and Medived Innovations amongst others. The India Cardiac pacemaker market is expected to grow at a CAGR of 18.5% from 2014-2019 due to greater influx of patients in cardiac care centers which has originated from rising awareness among the people about the right place for best treatment and will continue to escalate the growth of cardiac treatment in India.

China:

China has witnessed continuous and substantial rise in frequency of cardiac cases as well as deaths caused by cardiac disorders. This rapid rise has been attributed to factors such as changing lifestyles and dietary patterns, increasing consumption of tobacco, heavy smoking and several other proximate causes. The revenue of cardiac pacemaker market in China increased by 13.1% compared to 2013. The market has grown at a CAGR of 20.8%.. The China cardiac pacemaker has been anticipated to incline at a CAGR of 20.9% in 2019.

Japan:

The cardiac pacemaker market in Japan in the future is envisaged to augment at a CAGR of 13.0% during 2014-2019. Japan cardiac pacemaker market revenues have inclined at a CAGR of 8.7% in 2014. Japan cardiac pacemaker market in the outlook period, is likely to augment at a positive CAGR of 13.0% during 2014-2019, owing to consistent surging growth of cardiac disorders and innovations by these major players, coupled with enhancement in production capacity as well as extension in the coverage areas, towards newer states and expanding to newer geographies

South Korea:

South Korea's has highly fragmented cardiac pacemaker market, where major proportion of the market being covered by global pharmaceutical companies and very less in hands of local pharmaceutical companies.

Key Topics Covered:

1. Cardiac Pacemaker Market

2. India Cardiac Hospital Market

3. India Cardiac Pacemaker Market

4. China Cardiac Pacemaker Market

5. Japan Cardiac Pacemaker Market

6. South Korea Cardiac Pacemaker Market Snapshot

7. Asia-Pacific Cardiac Pacemaker Market Future Outlook and Projections, 2015-2019

8. Analyst Recommendations

9. Appendix

Companies Mentioned

- Medtronic

- Sorin Group

- Biotronik

- Boston Scientific Corporation

- St Jude Medical

- Medived Innovations Pvt Ltd

- Qinming Pharmaceuticals Ltd

- Fukuda Denshi

- Japan Lifeline

For more information visit http://www.researchandmarkets.com/research/fc6mpn/asia_pacific

View source version on businesswire.com: http://www.businesswire.com/news/home/20151130006133/en/